Sildenafil 20 MG
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
National Taiwan University Hospital
Overview
Sildenafil 20 MG is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Sildenafil 20 MG clinical trials
Explore related
Medical disclaimer. This page summarizes research about Sildenafil 20 MG for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.